The M3 Study
Type 2 Diabetes (T2D) in 16-40 year olds: A Multifactorial Management Intervention to Address Multimorbidity in Early-Onset T2D in Adults
In the past, type 2 diabetes mostly affected only older adults, but over recent years, the number of people being diagnosed at a younger age has increased. When type 2 diabetes occurs in people under the age of 40 it is considered ‘early onset’. Early-onset type 2 diabetes often occurs alongside other conditions such as obesity and high blood pressure, as well as mental health problems like anxiety or depression. It is also associated with an increased risk of developing harmful health problems over these people’s lives. People with early-onset type 2 diabetes often have complex, busy lives, and tell us that the care they receive doesn’t account for these complex circumstances.
In the M3 programme, we will design, develop and then test a new approach to care specifically tailored to people living with early-onset type 2 diabetes. To do this, we will work with people living with early-onset type 2 diabetes, health care professionals and decision-makers for the NHS. We will undertake a range of activities over 5 years, to design this new health care approach collectively, before testing it in a large clinical trial.
We are looking for people to take part in the M3 programme. If you are living with early-onset type 2 diabetes and would like to get involved, please contact the study team for more information.